Arkolith/Insider Trading/CMPX/Form 4

Gordon Carl L

Director, 10% OwnerCompass Therapeutics, Inc. (CMPX) · full profile →Form 4 · filed May 13, 2022
Net Buying
Open-Market Buys
$420K
Open-Market Sells
$0
Net Open-Market Flow
$420K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 13, 2022Buy(P)31K$2.49$76K14.8M
May 12, 2022Buy(P)97K$2.35$228K14.8M
May 11, 2022Buy(P)65K$1.79$116K14.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-22-000568) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML